PTEN and neoplasm: Upon GEM treatment, CAFs release exosomes loaded miR‐21, miR‐181a, miR‐221, miR‐222 and miR‐92a, which, by inhibiting PTEN expression, further encourage tumour cell proliferation and medication resistance.107